Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

Schneider, Bryan J; Naidoo, Jarushka; Santomasso, Bianca D; Lacchetti, Christina; Adkins, Sherry; Anadkat, Milan; Atkins, Michael B; Brassil, Kelly J; Caterino, Jeffrey M; Chau, Ian; Davies, Marianne J; Ernstoff, Marc S; Fecher, Leslie; Ghosh, Monalisa; Jaiyesimi, Ishmael; Mammen, Jennifer S; Naing, Aung; Nastoupil, Loretta J; Phillips, Tanyanika; Porter, Laura D; Reichner, Cristina A; Seigel, Carole; Song, Jung-Min; Spira, Alexander; Suarez-Almazor, Maria; Swami, Umang; Thompson, John A; Vikas, Praveen; Wang, Yinghong; Weber, Jeffrey S; Funchain, Pauline; Bollin, Kathryn

Schneider, Bryan J; Naidoo, Jarushka; Santomasso, Bianca D; Lacchetti, Christina; Adkins, Sherry; Anadkat, Milan; Atkins, Michael B; Brassil, Kelly J; Caterino, Jeffrey M; Chau, Ian; Davies, Marianne J; Ernstoff, Marc S; Fecher, Leslie; Ghosh, Monalisa; Jaiyesimi, Ishmael; Mammen, Jennifer S; Naing, Aung; Nastoupil, Loretta J; Phillips, Tanyanika; Porter, Laura D; Reichner, Cristina A; Seigel, Carole; Song, Jung-Min; Spira, Alexander; Suarez-Almazor, Maria; Swami, Umang; Thompson, John A; Vikas, Praveen; Wang, Yinghong; Weber, Jeffrey S; Funchain, Pauline; Bollin, Kathryn.

Afiliação

Schneider BJ; University of Michigan Health System, Ann Arbor, MI.
Naidoo J; Beaumont Hospital, Dublin, Ireland.
Santomasso BD; Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
Lacchetti C; Memorial Sloan Kettering Cancer Center, New York, NY.
Adkins S; American Society of Clinical Oncology, Alexandria, VA.
Anadkat M; MD Anderson Cancer Center, Houston, TX.
Atkins MB; Washington University, St Louis, MO.
Brassil KJ; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.
Caterino JM; MD Anderson Cancer Center, Houston, TX.
Chau I; The Ohio State University Wexner Medical Center, Columbus, OH.
Davies MJ; Royal Marsden Hospital and Institute of Cancer Research, London & Surrey, Sutton, UK.
Ernstoff MS; Smilow Cancer Hospital and Yale School of Nursing; New Haven, CT.
Fecher L; National Cancer Institute, Bethesda, MD.
Ghosh M; University of Michigan Health System, Ann Arbor, MI.
Jaiyesimi I; University of Michigan, Ann Arbor, MI.
Mammen JS; Cancer Care Associates PC, Royal Oak, MI.
Naing A; Johns Hopkins University, Baltimore, MD.
Nastoupil LJ; MD Anderson Cancer Center, Houston, TX.
Phillips T; MD Anderson Cancer Center, Houston, TX.
Porter LD; City of Hope, Duarte, CA.
Reichner CA; Patient Advocate, Colon Cancer Alliance, Washington, DC.
Seigel C; Georgetown University, Washington, DC.
Song JM; Patient Advocate, MGH Cancer Center, Boston, MA.
Spira A; Cleveland Clinic, Cleveland, OH.
Suarez-Almazor M; Virginia Cancer Specialists and US Oncology, Fairfax, VA.
Swami U; MD Anderson Cancer Center, Houston, TX.
Thompson JA; Huntsman Cancer Institute-University of Utah, Salt Lake City, UT.
Vikas P; Seattle Cancer Care Alliance, University of Washington/Fred Hutchinson, Seattle, WA.
Wang Y; University of Iowa, Iowa City, IA.
Weber JS; MD Anderson Cancer Center, Houston, TX.
Funchain P; NYU Langone Medical Center, New York, NY.
Bollin K; Cleveland Clinic, Cleveland, OH.

J Clin Oncol ; 39(36): 4073-4126, 2021 12 20.

Article em En | MEDLINE | ID: mdl-34724392

Assuntos

Inibidores de Checkpoint Imunológico/efeitos adversos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico Tipo de estudo: Guideline / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google